CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 96 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $318,000 | -28.1% | 23,300 | 0.0% | 0.13% | +6.5% |
| Q4 2015 | $442,000 | +1.1% | 23,300 | 0.0% | 0.12% | +47.6% |
| Q3 2015 | $437,000 | -89.3% | 23,300 | -91.5% | 0.08% | -78.3% |
| Q2 2015 | $4,102,000 | -5.3% | 275,500 | -3.7% | 0.39% | -5.4% |
| Q1 2015 | $4,333,000 | +10.7% | 286,100 | -2.6% | 0.41% | +9.1% |
| Q4 2014 | $3,913,000 | +5.6% | 293,800 | 0.0% | 0.38% | -1.8% |
| Q3 2014 | $3,705,000 | +13.4% | 293,800 | -9.2% | 0.38% | +35.9% |
| Q2 2014 | $3,268,000 | -24.4% | 323,600 | +0.7% | 0.28% | -20.4% |
| Q1 2014 | $4,320,000 | – | 321,200 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |